Sumitomo Mitsui Trust Holdings, Inc.
- SEC CIK
- 0001475365
- Latest filing
- Jul 30, 2026
The latest 13F from Sumitomo Mitsui Trust Holdings, Inc. covers Q2 2026 (filed Jul 30, 2026): 1,080 long positions worth $175.1B. The top 10 holdings make up 32.2% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 6.7%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 84
- Est. +$1.15B
- Added
- 350
- Est. +$2.43B
- Reduced
- 582
- Est. −$4.98B
- Sold out
- 51
- Est. −$634.5M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $175.1B
- +$20.6B (+13.3%) vs. prior quarter
- Positions
- 1,080
- +33 vs. prior quarter
- Top 10 concentration
- 32.2%
- Top 10 as share of value
- Turnover
- 2.2%
- Q2 2026, one quarter
- Average holding period
- 20.7 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $175.1B (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | 1,080 | $175.1B | NVDAAAPLMSFT | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 30, 2026 | 1,047 | $154.5B | NVDAAAPLMSFT | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 23, 2026 | 1,049 | $170.3B | NVDAAAPLMSFT | vs. Q3 2025 | SEC |
| Q3 2025 | Oct 27, 2025 | 1,050 | $173.8B | NVDAMSFTAAPL | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 31, 2025 | 1,034 | $160.5B | NVDAMSFTAAPL | vs. Q1 2025 | SEC |
| Q1 2025 | Apr 25, 2025 | 1,031 | $141.5B | AAPLMSFTNVDA | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 28, 2025 | 1,041 | $148.2B | AAPLNVDAMSFT | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 5, 2024 | 1,052 | $144.3B | AAPLMSFTNVDA | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 19, 2024 | 1,069 | $135.5B | MSFTNVDAAAPL | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 19, 2024 | 1,118 | $145.7B | MSFTAAPLNVDA | vs. Q4 2023 | SEC |
| Q4 2023 | Jan 30, 2024 | 1,122 | $135.3B | AAPLMSFTAMZN | vs. Q3 2023 | SEC |
| Q3 2023 | Oct 30, 2023 | 1,131 | $121.8B | AAPLMSFTNVDA | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 31, 2023 | 1,133 | $128.4B | AAPLMSFTAMZN | vs. Q1 2023 | SEC |
| Q1 2023 | Apr 27, 2023 | 1,146 | $134.2B | AAPLMSFTAMZN | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 30, 2023 | 1,180 | $126.3B | AAPLMSFTAMZN | vs. Q3 2022 | SEC |
| Q3 2022 | Oct 21, 2022 | 1,199 | $121.7B | AAPLMSFTAMZN | vs. Q2 2022 | SEC |
| Q2 2022 | Jul 26, 2022 | 1,214 | $130.0B | AAPLMSFTAMZN | vs. Q1 2022 | SEC |
| Q1 2022 | Apr 27, 2022 | 1,173 | $150.2B | AAPLMSFTAMZN | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 2, 2022 | 1,165 | $164.5B | AAPLMSFTAMZN | vs. Q3 2021 | SEC |
| Q3 2021 | Oct 25, 2021 | 1,182 | $160.6B | AAPLMSFTAMZN | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 2, 2021 | 1,182 | $169.1B | AAPLMSFTAMZN | vs. Q1 2021 | SEC |
| Q1 2021 | Apr 30, 2021 | 1,152 | $160.0B | AAPLMSFTAMZN | – | SEC |
13D and 13G filings
Companies where Sumitomo Mitsui Trust Holdings, Inc. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
3 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| ARCTArcturus Therapeutics Holdings Inc. | 13G/A | 7.20%1.95M shares | +0.10 ppfrom 7.10% | Feb 4, 20226 filings | Oct 27, 2025 | SEC |
| GCMGGCM Grosvenor Inc. | 13G/A | 6.20%3.75M shares | −1.30 ppfrom 7.50% | Jul 31, 20252 filings | Apr 30, 2026 | SEC |
| IXOrix Corp | 13G/A | 5.00%55.8M shares | – | Feb 5, 20215 filings | Jul 23, 2026 | SEC |
Latest filings
144 filings on file made by Sumitomo Mitsui Trust Holdings, Inc. or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| IXOrix Corp | Jul 23, 20266:01 AM ET | 13G/A | 5.00%55.8M shares | – | Jun 30, 2026 | SEC |
| GCMGGCM Grosvenor Inc. | Apr 30, 20266:04 AM ET | 13G/A | 6.20%3.75M shares | −1.30 ppfrom 7.50% | Mar 31, 2026 | SEC |
| SDGRSchrodinger, Inc. | Apr 30, 20266:04 AM ET | 13G/A | 4.90%3.19M shares | −2.20 ppfrom 7.10%Below 5% | Mar 31, 2026 | SEC |
| NMRNomura Holdings Inc | Feb 5, 20266:03 AM ET | 13G/A | 4.90%155.7M shares | –Below 5% | Dec 31, 2025 | SEC |
| IBTAIbotta, Inc. | Feb 5, 20266:01 AM ET | 13G/A | 1.50%341.3K shares | −3.60 ppfrom 5.10%Below 5% | Dec 31, 2025 | SEC |
| NXDRNextdoor Holdings, Inc. | Feb 5, 20266:00 AM ET | 13G/A | 4.90%11.9M shares | −0.80 ppfrom 5.70%Below 5% | Dec 31, 2025 | SEC |
| SDGRSchrodinger, Inc. | Oct 27, 20256:57 AM ET | 13G/A | 7.10%4.55M shares | +1.60 ppfrom 5.50% | Sep 30, 2025 | SEC |
| NXDRNextdoor Holdings, Inc. | Oct 27, 20256:57 AM ET | 13G | 5.70%13.7M shares | +1.60 ppfrom 4.10% | Sep 30, 2025 | SEC |
| ARCTArcturus Therapeutics Holdings Inc. | Oct 27, 20256:57 AM ET | 13G/A | 7.20%1.95M shares | +0.10 ppfrom 7.10% | Sep 30, 2025 | SEC |
| TXG10x Genomics, Inc. | Oct 27, 20256:57 AM ET | 13G/A | 4.70%5.38M shares | −0.70 ppfrom 5.40%Below 5% | Sep 30, 2025 | SEC |
| IBTAIbotta, Inc. | Oct 27, 20256:57 AM ET | 13G | 5.10%1.28M shares | New | Sep 30, 2025 | SEC |
| MUFGMitsubishi Ufj Financial Group Inc | Jul 31, 20256:14 AM ET | 13G/A | 4.90%595.5M shares | −0.10 ppfrom 5.00%Below 5% | Jun 30, 2025 | SEC |
| GCMGGCM Grosvenor Inc. | Jul 31, 20256:10 AM ET | 13G | 7.50%3.75M shares | New | Jun 30, 2025 | SEC |
| TXG10x Genomics, Inc. | Jul 31, 20256:07 AM ET | 13G | 5.40%6.01M shares | +0.40 ppfrom 5.00% | Jun 30, 2025 | SEC |
| TXG10x Genomics, Inc. | Apr 25, 20256:22 AM ET | 13G/A | 5.00%5.36M shares | – | Mar 31, 2025 | SEC |
| ARCTArcturus Therapeutics Holdings Inc. | Apr 25, 20256:18 AM ET | 13G/A | 7.10%1.93M shares | – | Mar 31, 2025 | SEC |
| ROKURoku, Inc | Feb 4, 20256:21 AM ET | 13G/A | 4.30%5.60M shares | –Below 5% | Dec 31, 2024 | SEC |
| QSIQuantum-Si Inc | Feb 4, 20256:19 AM ET | 13G/A | 4.80%5.97M shares | –Below 5% | Dec 31, 2024 | SEC |
| SDGRSchrodinger, Inc. | Feb 4, 20256:18 AM ET | 13G | 5.50%3.51M shares | New | Dec 31, 2024 | SEC |
| NXDRNextdoor Holdings, Inc. | Feb 4, 20256:17 AM ET | 13G/A | 4.10%8.91M shares | –Below 5% | Dec 31, 2024 | SEC |